Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
acP, adequacy, advent, Afghanistan, Afrezza, al, Alfort, Allerject, Alstom, aluminum, Amersham, amino, amyloid, Amyloidotic, analogue, anatagonist, andThe, anew, angiopoietin, ANSM, antidiabetic, Antiprotozoal, Aplenzin, Apleway, APOLLO, Ardelyx, Argentine, arrhythmic, arsenal, Asi, ASMD, assignee, augmented, Automotive, awaited, bacteraemia, ban, Barceloneta, Bassler, belief, BFSA, Bonnie, BP, Brandicourt, breakfast, BVBA, Cardiomyopathy, carfilzomib, cartridge, castration, CBD, Cdiff, CDRH, Celgene, CENCOEX, Centre, ceramide, chewable, Chi, Chicago, Cie, COMBO, Comit, compassionate, comunicated, confirmatory, contact, converged, coopting, crystallized, currenlty, Daiichi, deduced, Deerhaven, depth, designee, destroying, devaluation, dissatisfaction, downside, DRIRE, Dubai, DWG, Ebola, effervescent, Eligard, embarked, EoE, eosinophilic, epitope, EPM, eprinomectin, equine, erectile, ERT, Etat, Eudravigilance, eurozone, fastest, faute, febrile, Feline, FluQuadri, forfeited, Fresolimumab, FTFF, GAAP, GalNAc, Game, gastroenterology, Gastrogard, Globalpharma, glycoprotein, Gouvernement, granule, grave, grippal, Hall, Ho, honoraria, household, HQCB, HTA, Humalog, Humulin, hyperinflationary, IcyHot, IDC, IFPMA, Ilac, immunotherapy, Imovane, Importantly, incompatible, incumbent, inDeferred, industrialisation, infantile, inhaled, inhaler, inscription, inThe, irreversible, IRS, itemResearch, itemsOther, IU, Jean, Juvenile, KAEC, Kaleo, Kitasato, KK, Kron, Lancet, Lasix, lipid, lipoprotein, lispro, logo, LongRange, lourde, LP, male, Malmaison, mannkind, Margerie, marker, marketplace, MAT, maytansinoid, Medtronic, MEK, Methadone, microbiology, microwave, migration, milbemycin, milliardi, Minh, MirioPen, misconduct, ml, mounting, multicenter, Mumbai, musculoskeletal, mutated, myelin, MyoKardia, myostatin, Nagoya, nanoparticle, Nepal, nephrology, nerve, Neuropathy, neuroprotection, neutral, newNexGard, nose, nuanced, ofAmaryl, ofCompagnie, Officiel, ofLemtrada, ofNexGard, olipudase, Oliver, onNet, orOther, ou, oxime, pathology, Patrick, PCV, Pechiney, permission, permissive, peso, phosphoinositide, physicochemical, PJSC, PK, Planet, pomalidomide, ponazuril, pose, pourvoi, povidone, pragmatically, Praluent, pre, prefilled, pregnancy, preparatory, prequalified, Princeton, prioritization, prioritize, propelled, prorated, protozoal, PSUR, Purevax, quinoline, rDNA, reaction, reconfirmed, RecyCoal, referenced, refreshing, relabel, relocation, remyelination, Ren, repellent, repetition, RetinoStat, retrieval, retrieve, revusiran, risen, rival, RMS, roadmap, rollout, rouble, RP, RSV, Rueil, runny, RWG, sachet, Sanayi, sand, Saneca, Sankyo, SAR, SC, semisynthetic, sequence, SGBV, sheath, SICAD, SIMADI, simplicity, SK, SLE, SmartRelief, sneezing, SOLO, somatic, Sorbonne, SORELLA, speaking, Spectra, sphingomyelinase, steadily, sterile, straightforward, strictly, Sunshine, superseded, symptomatic, Syncytial, tadalafil, Takeda, teaching, theDirection, thefipronil, thehaut, Ticaret, tofogliflozin, Tolmar, Toujeo, toxicology, tubulin, UCB, ultrasound, unanimously, unilateral, unprecedent, unspecified, untreated, Unum, upside, urban, usability, Valeo, Vatelizumab, ve, versa, vital, vivo, VL, Vocal, voucher, watery, wave, weaken, whistleblower, worsen, wrote, younger
Removed:
AAD, AAV, abundant, Acomplia, acutely, admission, affiliated, aid, aluminium, appraisal, authorisation, baby, beauty, Belfer, Benzaclin, bio, bleeding, blower, Bombardier, bought, bowel, BTV, buoyed, capsule, capture, Carac, Carticel, Chondrocyte, chronically, Cincinnati, clearer, compensatory, comptable, concealed, concentrating, contesting, convenient, Copaxone, corridor, critically, Crucell, DDAVP, deferral, depression, dermatology, Dermik, destined, DFCI, DLBCL, dosing, Douro, dramatically, Duke, Eloxatine, enjoining, enregistrement, Epicel, esthetic, FASB, Ferring, Flutter, formula, Forum, fowl, fragment, Fresolumimab, Fuqua, genomic, Goiter, GRC, Greylock, grower, Hanspeter, harmonize, henceforth, Humaneered, IKK, ill, Implantation, inequitable, inflammatory, iPhone, ix, JPY, jury, kill, Landgericht, landmark, LDL, lice, loan, Lord, lymphocyte, MACI, mandated, Manhattan, Maryland, menopause, Metabolex, meter, monopolize, Monsanto, NICE, node, Nord, Oenobiol, ofCopaxone, ofFondation, originated, outbreak, outset, pa, Parkinson, passively, path, Pernod, pillar, planed, pool, premature, Prevelle, proved, pursued, QIV, reallocated, recruitment, regain, Renault, repayment, requalification, resolving, restate, retroactive, retrospectively, Ricard, Riceland, Richemont, rimonabant, RIT, rituximab, Rochester, Rock, scrupulously, Sculptra, Seikagaku, Seine, seriousPa, Sherman, sized, skincare, sound, Spek, squeeze, substrate, sued, suicidality, surgery, taxed, tertiary, ticker, toPa, TROPIC, TRV, USD, vanilloid, vi, vii, viii, violation, VKA, VTE, Warp, WCRX, wellbeing, Wellcome, whistle, whointer, Wyeth, Zactran, Zimmer, Zimulti
Filing tables
Filing exhibits
SNY similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-165418, 333-157685, 333-149203, 333-145074, 333-139555, 333-125490, 333-121584, and Form F-3 No.333-187156) of Sanofi of our reports dated March 10, 2015, with respect to the consolidated financial statements of Sanofi and its subsidiaries and the effectiveness of internal control over financial reporting of Sanofi and its subsidiaries, included in this Annual Report (Form 20-F) for the year ended December 31, 2014.
Paris-La Défense, France
March 10, 2015
Ernst & Young et Autres
Represented by Nicolas Pfeuty